Loading
Latest filing published 01 Sept 2026 for Quoin Pharmaceuticals, Ltd., €26k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Anthony James Culverwell is a declared insider at 2 companies; the most frequent names are Quoin Pharmaceuticals, Ltd. and Innocoll Holdings plc. The record holds 4 filings, for trades running from 24 July 2017 to 31 August 2026.
Purchases make up the whole of the open-market record (2 purchases, €69k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant. So far in 2026, the count stands at 1 purchase and no sales.
The latest filing, published on 1 September 2026, reports an open-market purchase of €26k in Quoin Pharmaceuticals, Ltd. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations